Metabolic flux analysis gives an insight on verapamil induced changes in central metabolism of HL-1 cells

Journal of Biotechnology

Volumn 155, Issue 3, 2011, Pages 299-307

  Strigun, Alexander ^a   Noor, Fozia ^a   Pironti, Alejandro ^b   Niklas, Jens ^a   Yang, Tae Hoon ^c   Heinzle, Elmar ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^c GENOMATICA INC   (United States)

Author keywords

Calcium channel blockers; Cardiomyocytes; Central metabolism; Glucose transport; Warburg effect

Indexed keywords

CALCIUM CHANNEL BLOCKERS; CARDIOMYOCYTES; CENTRAL METABOLISM; GLUCOSE TRANSPORT; WARBURG EFFECT;

AMINO ACIDS; BATCH DATA PROCESSING; CELL CULTURE; GLUCOSE; METABOLISM; PHYSIOLOGY; TUMORS;

CELLS;

ALANINE; CARBON 13; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL LINE; CELL METABOLISM; CELL RESPIRATION; CITRIC ACID CYCLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; GLUCOSE INTAKE; GLUCOSE TRANSPORT; GLYCOLYSIS; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CARBON ISOTOPES; CELL GROWTH PROCESSES; CELL LINE; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCOLYSIS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; METABOLOME; MICE; MYOCYTES, CARDIAC; OXYGEN; VERAPAMIL;

MURINAE;

EID: 80052390004     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2011.07.028     Document Type: Article

References (49)

1. Altamirano C., Paredes C., Cairo J.J., Godia F. Improvement of CHO cell culture medium formulation: simultaneous substitution of glucose and glutamine. Biotechnol. Prog. 2000, 16:69-75.
2. Andersson H., Kagedal B., Mandenius C.F. Monitoring of troponin release from cardiomyocytes during exposure to toxic substances using surface plasmon resonance biosensing. Anal. Bioanal. Chem. 2010, 398:1395-1402.
3. Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab. Eng. 2007, 9:68-86.
4. Ardizzone T.D., Lu X.H., Dwyer D.S. Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists. Am. J. Physiol. Cell Physiol. 2002, 283:C579-C586.
5. Bechtel L.K., Haverstick D.M., Holstege C.P. Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway. Acad. Emerg. Med. 2008, 15:368-374.
6. Beckers S., Noor F., Muller-Vieira U., Mayer M., Strigun A., Heinzle E. High throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements. Toxicol. In Vitro 2009, 24:686-694.
7. Bonarius H.P., Ozemre A., Timmerarends B., Skrabal P., Tramper J., Schmid G., Heinzle E. Metabolic-flux analysis of continuously cultured hybridoma cells using 13CO2 mass spectrometry in combination with 13C-lactate nuclear magnetic resonance spectroscopy and metabolite balancing. Biotechnol. Bioeng. 2001, 74:528-538.
8. Brogden R.N., Benfield P. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs 1996, 51:792-819.
9. Cartee G.D., Briggs-Tung C., Holloszy J.O. Diverse effects of calcium channel blockers on skeletal muscle glucose transport. Am. J. Physiol. 1992, 263:R70-R75.
10. Chen K., Liu Q., Xie L., Sharp P.A., Wang D.I. Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production. Biotechnol. Bioeng. 2001, 72:55-61.
11. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., Izzo N.J. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2979-2984.
12. Deng C., Rao F., Wu S., Kuang S., Liu X., Zhou Z., Shan Z., Lin Q., Qian W., Yang M., Geng Q., Zhang Y., Yu X., Lin S. Pharmacological effects of carvedilol on T-type calcium current in murine HL-1 cells. Eur. J. Pharmacol. 2009, 621:19-25.
13. Deshpande R., Yang T.H., Heinzle E. Towards a metabolic and isotopic steady state in CHO batch cultures for reliable isotope-based metabolic profiling. Biotechnol. J. 2009, 4:247-263.
14. Eimre M., Paju K., Pelloux S., Beraud N., Roosimaa M., Kadaja L., Gruno M., Peet N., Orlova E., Remmelkoor R., Piirsoo A., Saks V., Seppet E. Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes. Biochim. Biophys. Acta 2008, 1777:514-524.
15. Fox J.E., Jones L., Light P.E. Identification and pharmacological characterization of sarcolemmal ATP-sensitive potassium channels in the murine atrial HL-1 cell line. J. Cardiovasc. Pharmacol. 2005, 45:30-35.
16. Fritzsche M., Fredriksson J.M., Carlsson M., Mandenius C.F. A cell-based sensor system for toxicity testing using multiwavelength fluorescence spectroscopy. Anal. Biochem. 2009, 387:271-275.
17. Gambhir A., Europa A.F., Hu W.S. Alteration of cellular metabolism by consecutive fed-batch cultures of mammalian cells. J. Biosci. Bioeng. 1999, 87:805-810.
18. Gatenby R.A., Gillies R.J. Glycolysis in cancer: a potential target for therapy. Int. J. Biochem. Cell Biol. 2007, 39:1358-1366.
19. Gillies R.J., Gatenby R.A. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?. J. Bioenerg. Biomembr. 2007, 39:251-257.
20. Goudar C., Biener R., Boisart C., Heidemann R., Piret J., de Graaf A., Konstantinov K. Metabolic flux analysis of CHO cells in perfusion culture by metabolite balancing and 2D [13C, 1H] COSY NMR spectroscopy. Metab. Eng. 2010, 12:138-149.
21. Hans M.A., Heinzle E., Wittmann C. Free intracellular amino acid pools during autonomous oscillations in Saccharomyces cerevisiae. Biotechnol. Bioeng. 2003, 82:143-151.
22. Henry O., Jolicoeur M., Kamen A. Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis. Bioprocess Biosyst. Eng. 2011, 34:263-273.
23. Kaplan N.M. Calcium entry blockers in the treatment of hypertension. Current status and future prospects. JAMA 1989, 262:817-823.
24. Kim S.H., Lee G.M. Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin. Appl. Microbiol. Biotechnol. 2007, 74:152-159.
25. Kromer J.O., Fritz M., Heinzle E., Wittmann C. In vivo quantification of intracellular amino acids and intermediates of the methionine pathway in Corynebacterium glutamicum. Anal. Biochem. 2005, 340:171-173.
26. Louters L.L., Stehouwer N., Rekman J., Tidball A., Cok A., Holstege C.P. Verapamil inhibits the glucose transport activity of GLUT1. J. Med. Toxicol. 2010, 6:100-105.
27. Maier K., Hofmann U., Bauer A., Niebel A., Vacun G., Reuss M., Mauch K. Quantification of statin effects on hepatic cholesterol synthesis by transient 13C-flux analysis. Metab. Eng. 2009, 11:292-309.
28. Maranga L., Goochee C.F. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels. Biotechnol. Bioeng. 2006, 94:139-150.
29. Monge C., Beraud N., Tepp K., Pelloux S., Chahboun S., Kaambre T., Kadaja L., Roosimaa M., Piirsoo A., Tourneur Y., Kuznetsov A.V., Saks V., Seppet E. Comparative analysis of the bioenergetics of adult cardiomyocytes and nonbeating HL-1 cells: respiratory chain activities, glycolytic enzyme profiles, and metabolic fluxes. Can. J. Physiol. Pharmacol. 2009, 87:318-326.
30. Niklas J., Noor F., Heinzle E. Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2. Toxicol. Appl. Pharmacol. 2009, 240:327-336.
31. Niklas J., Schneider K., Heinzle E. Metabolic flux analysis in eukaryotes. Curr. Opin. Biotechnol. 2010, 21:63-69.
32. Niklas J., Schräder E., Sandig V., Noll T., Heinzle E. Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis. Bioprocess Biosyst. Eng. 2011, 34:533-545. 10.1007/s00449-010-0502-y.
33. Oeggerli A., Eyer K., Heinzle E. On-line gas analysis in animal cell cultivation: I. Control of dissolved oxygen and pH. Biotechnol. Bioeng. 1995, 45:42-53.
34. Sartiani L., Bochet P., Cerbai E., Mugelli A., Fischmeister R. Functional expression of the hyperpolarization-activated, non-selective cation current If in immortalized HL-1 cardiomyocytes. J. Physiol. 2002, 545:81-92.
35. Schmidt W.F., Huber K.R., Ettinger R.S., Neuberg R.W. Antiproliferative effect of verapamil alone on brain tumor cells in vitro. Cancer Res. 1988, 48:3617-3621.
36. Shuralyova I., Tajmir P., Bilan P.J., Sweeney G., Coe I.R. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H627-H632.
37. Sidorenko Y., Wahl A., Dauner M., Genzel Y., Reichl U. Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media. Biotechnol. Prog. 2008, 24:311-320.
38. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
39. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance in P388 Leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981, 41:1967-1972.
40. Vo T.D., Palsson B.O. Isotopomer analysis of myocardial substrate metabolism: a systems biology approach. Biotechnol. Bioeng. 2006, 95:972-983.
41. Weiss S., John G.T., Klimant I., Heinzle E. Modeling of mixing in 96-well microplates observed with fluorescence indicators. Biotechnol. Prog. 2002, 18:821-830.
42. White S.M., Constantin P.E., Claycomb W.C. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H823-H829.
43. Xia M., Salata J.J., Figueroa D.J., Lawlor A.M., Liang H.A., Liu Y., Connolly T.M. Functional expression of L- and T-type Ca2+ channels in murine HL-1 cells. J. Mol. Cell. Cardiol. 2004, 36:111-119.
44. Xu C., He J.Q., Kamp T.J., Police S., Hao X., O'Sullivan C., Carpenter M.K., Lebkowski J., Gold J.D. Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev. 2006, 15:931-941.
45. Yang T.H., Bolten C.J., Coppi M.V., Sun J., Heinzle E. Numerical bias estimation for mass spectrometric mass isotopomer analysis. Anal. Biochem. 2009, 388:192-203.
46. Yang T.H., Frick O., Heinzle E. Hybrid optimization for 13C metabolic flux analysis using systems parametrized by compactification. BMC Syst. Biol. 2008, 2:29.
47. Zhang C., Lv F., Zhou L., Li X., Wu X.X., Hoffman R.M. Effect of verapamil on the expression of EGFR and NM23 in A549 human lung cancer cells. Anticancer Res. 2009, 29:27-32.
48. Zhang L., Yang Y., Wei X.Y., Shi Y.R., Liu H.Y., Niu R.F., Hao X.S. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil. J. Exp. Clin. Cancer Res. 2007, 26:201-207.
49. Zhou W., Rehm J., Hu W.S. High viable cell concentration fed-batch cultures of hybridoma cells through on-line nutrient feeding. Biotechnol. Bioeng. 1995, 46:579-587.